Literature DB >> 14501668

Outcome analysis of simple and complex urethrocutaneous fistula closure using a de-epithelialized or full thickness skin advancement flap for coverage.

Kristin Santangelo1, H Gil Rushton, A Barry Belman.   

Abstract

PURPOSE: We review our experience repairing simple and complex urethrocutaneous fistulas using a de-epithelialized or full thickness skin advancement flap for 2-layer coverage over the fistula.
MATERIALS AND METHODS: We reviewed the records of 1,092 hypospadias repairs performed at our institution. Urethrocutaneous fistula developed in 66 of those patients and 33 additional patients with fistula were referred from elsewhere. These 99 patients underwent a total of 94 fistula repairs. For simple repairs a de-epithelialized flap or a skin advancement flap was used. For complex repairs a variety of techniques were performed, all with a de-epithelialized skin flap for coverage. Stents were not left postoperatively in simple cases and repairs were routinely performed as outpatient procedures.
RESULTS: Overall there were 6 (6.4%) failures. In 69 cases (73%) simple fistula closure was covered by a de-epithelialized flap or skin advancement flap, which failed in 3 (4.3%). Of 25 patients who required more complex repairs 18 underwent a tubularized or onlay urethroplasty incorporating the fistula, which failed in 2 (11.1%). Two patients underwent meatoplasty in conjunction with the distal fistula repair, which failed in 1. Two patients underwent urethroplasty in conjunction with separate repair of a urethrocutaneous fistula, and there were no failures. No fistula developed in 3 cases of re-do hypospadias repairs.
CONCLUSIONS: Excellent results can be achieved for simple and complex urethrocutaneous fistula closure using a de-epithelialized or full thickness advancement flap. Moreover, almost all repairs can be performed in an outpatient setting. Simple closures do not require stenting postoperatively.

Entities:  

Mesh:

Year:  2003        PMID: 14501668     DOI: 10.1097/01.ju.0000084624.17496.29

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  7 in total

1.  Novel use of Asopa technique for penile urethrocutaneous fistula repair.

Authors:  Nathan M Shaw; Clare Mallahan; Pankaj Joshi; Krishnan Venkatesan; Sanjay Kulkarni
Journal:  Int Urol Nephrol       Date:  2021-01-02       Impact factor: 2.370

2.  [Patio repair for urethrocutaneous fistulae : Results of a multicentre retrospective study].

Authors:  J Kranz; O A Brinkmann; B Brinkmann; J Steffens; P Malone
Journal:  Urologe A       Date:  2017-10       Impact factor: 0.639

3.  Posttraumatic ventral urethral fistula: a case report.

Authors:  Mehmet Yucel; Sahin Kabay; Levent Sahin; Mustafa Koplay; Soner Yalcinkaya; Tayfun Cucioglu; Namik Kemal Hatipoglu
Journal:  Cases J       Date:  2009-09-03

4.  Traction-assisted dissection with soft tissue coverage is effective for repairing recurrent urethrocutaneous fistula following hypospadias surgery.

Authors:  Takanori Ochi; Shogo Seo; Yuta Yazaki; Manabu Okawada; Takashi Doi; Go Miyano; Hiroyuki Koga; Geoffrey J Lane; Atsuyuki Yamataka
Journal:  Pediatr Surg Int       Date:  2014-12-18       Impact factor: 1.827

5.  A novel technique for repair of mid-penile hypospadias using a preputial skin flap: results of 110 patients.

Authors:  Hazem Elmoghazy; Mohamed M Hussein; Elnisr Mohamed; Abdelbasset Badawy; Gamal Alsagheer; Ahmed Mamdouh Abd Elhamed
Journal:  Int Urol Nephrol       Date:  2016-09-13       Impact factor: 2.370

6.  Urethrocutaneous fistula after hypospadias repair: outcome of three types of closure techniques.

Authors:  Kaliyaperumal Muruganandham; M S Ansari; Deepak Dubey; Anil Mandhani; Aneesh Srivastava; Rakesh Kapoor; Anant Kumar
Journal:  Pediatr Surg Int       Date:  2009-10-14       Impact factor: 1.827

7.  Use of autologous platelet rich fibrin in urethracutaneous fistula repair: preliminary report.

Authors:  Tutku Soyer; Murat Çakmak; Mustafa K Aslan; Mine F Şenyücel; Üçler Kisa
Journal:  Int Wound J       Date:  2012-05-09       Impact factor: 3.315

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.